ロード中...
Development of liposomal gemcitabine with high drug loading capacity
Liposomes are widely used for systemic delivery of chemotherapeutic agents to reduce their nonspecific side effects. Gemcitabine (Gem) makes a great candidate for liposomal encapsulation due to the short half-life and non-specific side effects; however, it has been difficult to achieve liposomal Gem...
保存先:
| 出版年: | Mol Pharm |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6662591/ https://ncbi.nlm.nih.gov/pubmed/31136710 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.8b01284 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|